Get the Stockscreener App
104.99
1.44%
-1.53
After Hours:
104.06
-0.93
-0.89%
Spdr Biotech Etf stock is traded at $104.99, with a volume of 16.93M.
It is down -1.44% in the last 24 hours and up +11.81% over the past month.
See More
Previous Close:
$106.52
Open:
$107.005
24h Volume:
16.93M
Relative Volume:
1.78
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.34%
1M Performance:
+11.81%
6M Performance:
+46.61%
1Y Performance:
+9.11%
1-Day Range:
$104.13
$107.08
1-Week Range:
$102.55
$107.26
52-Week Range:
$66.66
$107.26
Spdr Biotech Etf Stock (XBI) Company Profile
Name
Spdr Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
Spdr Biotech Etf
|
104.99 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
321.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
653.02 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
656.20 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
248.10 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
589.50 | 124.43B | 0 | 0 | 0 | 0.00 |
Spdr Biotech Etf Stock (XBI) Latest News
Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com
Price-Driven Insight from (XBI) for Rule-Based Strategy - news.stocktradersdaily.com
Behavioral Patterns of XBI and Institutional Flows - news.stocktradersdaily.com
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
Understanding Momentum Shifts in (XBI) - news.stocktradersdaily.com
(XBI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. - Barron's
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
Why (XBI) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Responsive Playbooks and the XBI Inflection - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (XBI) Edition - news.stocktradersdaily.com
The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com
(XBI) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
(XBI) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
The Best Biotech ETFs to Buy - inkl
SPDR S&P Biotech ETF Options Spot-On: On October 1st, 120.99K Contracts Were Traded, With 703.1K Open Interest - 富途牛牛
Avoiding Lag: Real-Time Signals in (XBI) Movement - news.stocktradersdaily.com
6 Best Health Care Funds and ETFs for 2025 - US News Money
Howard Capital Management Group LLC Sells 865 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Farther Finance Advisors LLC Buys 6,032 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Banque Pictet & Cie SA Trims Stake in SPDR S&P Biotech ETF $XBI - Defense World
Fifth Third Bancorp Sells 22,252 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Understanding the Setup: (XBI) and Scalable Risk - news.stocktradersdaily.com
Embree Financial Group Lowers Position in SPDR S&P Biotech ETF $XBI - Defense World
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Financial Management Professionals Inc. Trims Holdings in SPDR S&P Biotech ETF $XBI - Defense World
(XBI) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
SPDR S&P Biotech ETF (XBI) Top 25 Holdings - TIKR.com
Biotech Stocks Rally. 3 Favorite Plays From the Charts. - MSN
Biotech Stocks Rally. 3 Favorite Plays From the Charts. -- Barrons.com - 富途牛牛
Trading Systems Reacting to (XBI) Volatility - news.stocktradersdaily.com
CrowdStrike, SoFi, Clearway Energy And More: CNBC's 'Final Trades' - Benzinga
Spdr Biotech Etf Stock (XBI) Financials Data
There is no financial data for Spdr Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):